Why Is IRIM11 Falling?
Three pressures are hitting the fund at the same time: digesting the assets inherited from the IRDM11 merger (November 2025), the normalization of distributions—which dropped from R$ 1.18 in June 2026 to R$ 0.77 in July 2026 when accumulated inflation stopped inflating the payout—and an oversupply of units from legacy sellers. Together, these factors have pulled the unit price down from its 12-month high to its current level of R$ 60.45.
IRIM11 (Iridium FII) is a paper fund: instead of physical properties, it holds 157 CRIs (Real Estate Receivables Certificates)—debt securities backed by the real estate sector—which represent about 74% of its net asset value, alongside a portfolio of 23 FIIs (~20%) and cash. This is where the monthly distributions come from. To understand why the unit price has fallen, we need to separate three forces that converged during the same period—none of which will resolve in a single trading session.
The Merger's Legacy: Recycling Troubled FIIs
The absorption of IRDM11 by IRIM11 was finalized on November 18, 2025, doubling the fund's net asset value, which now stands at R$ 2.90 billion with 35,225,947 units outstanding. However, a merger isn't just about combining quality assets: along with the CRI portfolio came stakes in FIIs of varying quality—names like HCTR11, DEVA11, MANA11, and TORD11—that management must gradually sell off to realign the portfolio with IRIM's strategy.
This process carries a visible accounting cost. Selling an FII unit below its purchase price generates a negative FII result in certain months, which is precisely what shows up in the distribution breakdown during the transition. In July 2026, management wound down its position in HDOF11, following earlier swaps in CPSH11/EIRA11 and sales of RBHY11 and TORD11. Each of these exits represents a piece of the legacy portfolio being unwound—and while that happens, it weighs on earnings.
There is also a perception noise that amplified the pressure. In August 2026, an Itaú report on the fund mentioned assets that, according to unitholders (brunofmoura reported this point following a live broadcast), were no longer in the portfolio—management itself reportedly commented that the material appeared outdated. The problem is that the market prices what it reads, and a report misaligned with the actual portfolio fuels distrust just as a new buying base is trying to form.
The recycling of inherited FIIs has a timeline: according to management statements, the process is expected to wrap up by the end of 2026. Once it concludes, the recurring source of negative FII results will disappear—but until then, it will continue to show up month after month in the distributions.
The End of Extraordinary Inflation Adjustments: Why the Distribution Dropped From R$ 1.18 to R$ 0.77
This is the point that causes the most confusion for anyone looking only at the headline number. The distribution of R$ 1.18 paid in June 2026 was a non-recurring spike—and understanding why is the key to understanding how the fund operates.
Since 87.8% of the CRI portfolio is indexed to the IPCA inflation index (equivalent to about 78% of total net asset value), the fund's monthly revenue depends on inflation rates. However, IPCA adjustments on CRIs enter with a time lag: a given month's inflation only materializes in the fund's cash flow weeks later. When months of stronger inflation accumulate and arrive all at once, combined with principal amortizations and one-off premiums, the monthly result balloons—which is what produced the R$ 1.18 payout in June. That is not recurring cash generation; it is temporary accumulation arriving at once.
As inflation cooled throughout 2026, this accumulation dried up. In July 2026, the fund distributed R$ 0.77 per unit (a 1.18% distribution yield based on the price at the time, R$ 65.09), paid on August 18. The month's figures show a healthy fund, not one in trouble: generated cash reached R$ 28.29 million, with R$ 27.12 million distributed—a payout ratio of 95.88%—leaving R$ 0.31 per unit set aside in accumulated reserves. The distribution fell because extraordinary revenue ended, not because the fund stopped generating cash.
Management itself signaled in the July managerial report that "lower inflation should impact upcoming distributions." This confirmed, in the words of those managing the fund, that the R$ 1.18 level would not return anytime soon. The market is still digesting this normalization—investors who had extrapolated the annualized peak found themselves facing a much lower recurring distribution and repriced the units downward. The recent history makes the amplitude clear:
| Month | Distribution / Unit | Note |
|---|---|---|
| February 2026 | R$ 0.80 | Yield 1.25% (price R$ 63.97) |
| March 2026 | R$ 0.75 | Yield 1.14% |
| April 2026 | R$ 0.90 | Highest since merger |
| May 2026 | R$ 0.95 | Yield 1.42% |
| June 2026 | R$ 1.18 | Non-recurring spike |
| July 2026 | R$ 0.77 | Return to recurring level |
Recurring income measured over the twelve-month window (August 2025 to July 2026) sits around R$ 0.803 per unit. This figure—rather than the June peak—represents the fund's true day-to-day income-generating capacity. For a detailed history of the month of July, see the IRIM11 July earnings report.
Excess Units in the Market: The Buying Base Is Still Forming
The third pressure is the most mechanical of the three—and the least tied to fundamentals. By absorbing IRDM11, IRIM11 inherited not just assets, but unitholders: people who had bought IRDM for one thesis and overnight found themselves owning a fund with a different name, portfolio management, and strategy. Some of these legacy investors do not identify with the new vehicle and continue to sell.
There are 35.2 million units circulating among roughly 200,000 unitholders, nearly all of them retail investors (99.86%). When selling pressure from those looking to exit outweighs demand from those looking to enter, prices give way—regardless of book value. This is the classic post-merger dynamic: the legacy selling base takes months to exhaust itself, and the buying base that believes in the new thesis is still forming. As long as this imbalance exists, units will likely trade under pressure even without any deterioration in fundamentals.
This disconnect between price and book value is precisely what produces the 0.73 price-to-book ratio: units trade at R$ 60.45 in the market against a book value of R$ 82.29. The merger had already delivered the initial push—post-merger, units retreated from R$ 74.96 to R$ 62.45 in March 2026, a 17% drop in four months. The move down to the current level is a continuation of that same digestion process.
Active Borrower Monitoring. The August 2026 managerial report notes that management maintains about 6% of net assets in CRIs under active monitoring. This is not a declared default—it is close tracking of credits requiring attention, and their outcome will influence both the portfolio's mark-to-market valuation and future distribution flows. It is an item to monitor, not an announced writedown.
What to Expect Moving Forward
With the three pressures mapped out, the next steps for the IRIM11 real estate fund depend on concrete, datable milestones—not price forecasts. Short-term distributions hover around the recurring generation of R$ 0.803 per unit, cushioned by the R$ 0.31 per unit reserve that management can tap to smooth out weak months. The scenarios factored into our analysis are:
| Scenario | Estimated DPU | Premise |
|---|---|---|
| Optimistic | R$ 0.90 | Inflation above expectations |
| Base | R$ 0.78 | Inflation ~4.5% p.a. |
| Pessimistic | < R$ 0.78 | Weak inflation + persistent selling pressure |
On the asset side, the trajectory of the price-to-book ratio also points to different outcomes: in the base scenario, the analysis projects the price-to-book moving toward ~0.82 in about 36 months; in the optimistic scenario, toward ~0.90 in ~24 months; and in the pessimistic scenario, remaining at ~0.72 for up to 36 months. In all of them, the current 27% discount does not vanish overnight—it closes (or doesn't) as the three pressures resolve.
There is a potential positive catalyst on the table. The Pátio Malzoni CRI, which accounts for about 1.38% of net asset value, could undergo prepayment if the sale of the asset to TRXF is confirmed—a possibility raised by unitholders (kraftael commented on this point). Prepayment returns cash to the fund, which can be reinvested in CRIs with better yields. It is not guaranteed; it is a trigger to monitor.
In short, the 0.73 price-to-book ratio coexists with a diversified portfolio of 157 CRIs, a mark-to-market yield of IPCA + 10.9%, a 3.5-year duration, and only point-in-time leverage (reverse repurchase agreement of 2.4% of net asset value at CDI + 0.4%, non-structural, to be settled with amortizations). The discount exists—but what the market is pricing in alongside it is the combination of soft inflation ahead and ongoing legacy selling pressure. For unitholders, the events defining the next chapter have dates and names: the path of inflation over the coming months, the completion of the legacy FII recycling by the end of 2026, the outcome of the Malzoni CRI, and the performance of the 6% of net assets in monitored CRIs. It is these milestones—rather than any single trading day—that will determine whether these three pressures are dissipating or deepening.
